Tobacco is deadly. Calling it ‘popular’ may send the wrong message

  Stephanie R. Land and Wen-Ying Sylvia Chou National Cancer Institute, USA Tobacco control efforts are regularly complicated by the entry of new tobacco products into the marketplace. New products are often not well understood by the public, including members of the target markets, healthcare professionals, and community leaders. For example, we may lack information […]

Read More…

China: CTI’s quiet expansion strategy should be a concern for global public health

Ross MacKenzie, Jennifer Fang, Julia Smith In July this year, China Tobacco International (CTI) Hong Kong, the international arm of the China National Tobacco Corporation (CNTC), launched into the stock market with an initial public offering (IPO). Outside of the financial media, the IPO attracted relatively little attention. However, the offering has implications far beyond […]

Read More…

World: Gandhi’s legacy and a Tobacco-Free World

From Indian public health researchers Amit Yadav and Prashant Kumar Singh, a call to action for world leaders to take action at the UN General Assembly on the eve of Gandhi’s 150th birthday.  “A correspondent who is interested in a variety of reforms asks what the nation pays for her tobacco bill.  I find that […]

Read More…

Canada: government releases consumer research on vaping and tobacco

Cynthia Callard, Physicians for a Smoke-Free Canada The Canadian nicotine market was transformed virtually overnight after the government of Canada legalized the sale of vaping products in May 2018. Previously, Canadians were able to buy unregulated vaping devices and liquids online or in a modest number of illegally-operating shopfronts. Their choice of device, however, was […]

Read More…

World: PMI-funded Foundation for a Smoke-Free World adding insult to injury

Jennifer Fang and Kelley Lee Despite 7 million deaths annually and counting, tobacco control worldwide continues to be seriously underfunded as a public health priority. This funding gap is especially acute in low-income countries and among certain historically disadvantaged populations.  It is into this space that the Philip Morris International (PMI) financed Foundation for a […]

Read More…

Responding to public health emergencies in an age of distrust: the current lung damage epidemic in the United States

Bill King, Coral Gartner and Ron Borland In April 2019, the first case appeared of what soon became an epidemic of highly unusual lung damage cases in the United States, with the patients first presenting for medical treatment with a form of lipoid pneumonia. The US Centers for Disease Control and Prevention (CDC), the Food […]

Read More…

USA: Setting the Sun on Big Tobacco

Megan Arendt, ASH USA The U.S. Centers for Disease Control (CDC) held their National Conference on Tobacco or Health (NCTOH) in Minneapolis, MN from August 27 – 29, 2019. It was an exciting week for public health experts, advocates, researchers, and policymakers to network and learn from each other, in turn strengthening public health policies […]

Read More…

Indonesia: the continued expansion of JUUL from the USA

Elizabeth Orlan, Rachel Grana, and Mark Parascandola In early July, we authored an industry watch article JUUL from the USA to Indonesia, published in Tobacco Control. It outlined moves by JUUL to formally enter the Indonesian market, where the products were already being sold both online and in vape shops. JUUL has now officially launched […]

Read More…

China: Tobacco and Belt and Road Initiative – the new ‘Go Global’?

Jennifer Fang China National Tobacco Company (CNTC) is the world’s largest manufacturer of cigarettes, accounting for a third of the total global output. The powerful state-owned tobacco monopoly, previously focused on the vast domestic market with 350 million smokers, has been nurturing growing global ambitions since the early 2000s. Faced by an increasingly saturated domestic […]

Read More…